Gene · 8932
Papers2,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The synergistic interaction landscape of chromatin regulators reveals their epigenetic regulation mechanisms across five cancer cell lines. | Comput Struct Biotechnol J | 2022 | 36187922 | PubTator, text mining | PubMed |
| Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs. | Front Physiol | 2022 | 36187762 | PubTator, text mining | PubMed |
| MKRN3 role in regulating pubertal onset: the state of art of functional studies. | Front Endocrinol (Lausanne) | 2022 | 36187104 | PubTator, text mining | PubMed |
| Role of 5-methylcytosine in determining the prognosis, tumor microenvironment, and applicability of precision medicine in patients with hepatocellular carcinoma. | Front Genet | 2022 | 36186468 | PubTator, text mining | PubMed |
| Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. | Front Genet | 2022 | 36186426 | PubTator, text mining | PubMed |
| MeCP2 heterochromatin organization is modulated by arginine methylation and serine phosphorylation. | Front Cell Dev Biol | 2022 | 36172281 | PubTator, text mining | PubMed |
| DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma. | Aging (Albany NY) | 2022 | 36152044 | PubTator, text mining | PubMed |
| A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma. | Front Immunol | 2022 | 36148220 | PubTator, text mining | PubMed |
| The Role of DNA Methylation in Stroke Recovery. | Int J Mol Sci | 2022 | 36142283 | PubTator, text mining | PubMed |
| Analyzing integrated network of methylation and gene expression profiles in lung squamous cell carcinoma. | Sci Rep | 2022 | 36138066 | PubTator, text mining | PubMed |
| The Yin and Yang of epigenetics in the field of nanoparticles. | Nanoscale Adv | 2022 | 36131763 | PubTator, text mining | PubMed |
| FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ. | Sci Adv | 2022 | 36129980 | PubTator, text mining | PubMed |
| Potential epigenetic molecular regulatory networks in ocular neovascularization. | Front Genet | 2022 | 36118885 | PubTator, text mining | PubMed |
| Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. | Signal Transduct Target Ther | 2022 | 36115852 | PubTator, text mining | PubMed |
| m5C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma. | Front Genet | 2022 | 36092897 | PubTator, text mining | PubMed |
| DNA methylation regulators-related molecular patterns and tumor immune landscape in hepatocellular carcinoma. | Front Oncol | 2022 | 36091162 | PubTator, text mining | PubMed |
| Blockade of Mbd2 by siRNA-loaded liposomes protects mice against OVA-induced allergic airway inflammation via repressing M2 macrophage production. | Front Immunol | 2022 | 36090987 | PubTator, text mining | PubMed |
| Targeting Aberrant Histone Posttranscription Modification Machinery in Esophageal Squamous Cell Carcinoma: Current Findings and Challenges. | Research (Wash D C) | 2022 | 36072272 | PubTator, text mining | PubMed |
| Copper binding leads to increased dynamics in the regulatory N-terminal domain of full-length human copper transporter ATP7B. | PLoS Comput Biol | 2022 | 36070320 | PubTator, text mining | PubMed |
| Computational discovery of novel inhibitory candidates targeting versatile transcriptional repressor MBD2. | J Mol Model | 2022 | 36066769 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8932/papers?page=21